Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551. (2nd September 2017)

Record Type:: Journal Article
Title:: Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551. (2nd September 2017)
Main Title:: Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551
Authors:: Min, T.
Wali, L.
Williams, D.M.
Plummer, E.
Gurung, A.
Stephens, J.W.
Abstract:
Is Part Of:: Current medical research and opinion. Volume 33:Number 9(2017)
Journal:: Current medical research and opinion
Issue:: Volume 33:Number 9(2017)
Issue Display:: Volume 33, Issue 9 (2017)
Year:: 2017
Volume:: 33
Issue:: 9
Issue Sort Value:: 2017-0033-0009-0000
Page Start:: 1715
Page End:: 1716
Publication Date:: 2017-09-02
Subjects:: Clinical medicine -- Periodicals
Therapeutics -- Periodicals
615.5
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/03007995.2017.1336432 ↗
Languages:: English
ISSNs:: 0300-7995
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3500.301000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 4422.xml